Medicare Part D Formulary Updates
CMS is moving from annual reviews of the Part D prescription drug program model formulary to a three-year review cycle, given the "success and stabilization of recent versions of the Model Guidelines."
Trackbacks (0)
Links to blogs that reference this article
Trackback URL
http://www.healthindustrywashingtonwatch.com/admin/trackback/73418
http://www.healthindustrywashingtonwatch.com/admin/trackback/73418
Comments (0)
Read through and enter the discussion with the form at the end
Post A Comment / Question
Use this form to add a comment to this entry.
Send To A Friend
Use this form to send this entry to a friend via email.
